These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 25862488)

  • 1. Focal adhesion kinase and p53 synergistically decrease neuroblastoma cell survival.
    Gillory LA; Stewart JE; Megison ML; Waters AM; Beierle EA
    J Surg Res; 2015 Jun; 196(2):339-49. PubMed ID: 25862488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of FAK and VEGFR-3 binding decreases tumorigenicity in neuroblastoma.
    Stewart JE; Ma X; Megison M; Nabers H; Cance WG; Kurenova EV; Beierle EA
    Mol Carcinog; 2015 Jan; 54(1):9-23. PubMed ID: 23868727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The interaction between FAK, MYCN, p53 and Mdm2 in neuroblastoma.
    Waters AM; Beierle EA
    Anticancer Agents Med Chem; 2014 Jan; 14(1):46-51. PubMed ID: 24041229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting focal adhesion kinase in neuroblastoma.
    Gillory L; Beierle EA
    Anticancer Agents Med Chem; 2010 Dec; 10(10):714-21. PubMed ID: 21269252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MYCN, neuroblastoma and focal adhesion kinase (FAK).
    Beierle EA
    Front Biosci (Elite Ed); 2011 Jan; 3(2):421-33. PubMed ID: 21196322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Focal adhesion kinase and p53 signal transduction pathways in cancer.
    Golubovskaya VM; Cance W
    Front Biosci (Landmark Ed); 2010 Jun; 15(3):901-12. PubMed ID: 20515733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Focal adhesion kinase versus p53: apoptosis or survival?
    Cance WG; Golubovskaya VM
    Sci Signal; 2008 May; 1(20):pe22. PubMed ID: 18493017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FAK and p53 protein interactions.
    Golubovskaya VM; Cance WG
    Anticancer Agents Med Chem; 2011 Sep; 11(7):617-9. PubMed ID: 21355845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of focal adhesion kinase decreases tumor growth in human neuroblastoma.
    Beierle EA; Ma X; Stewart J; Nyberg C; Trujillo A; Cance WG; Golubovskaya VM
    Cell Cycle; 2010 Mar; 9(5):1005-15. PubMed ID: 20160475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct interaction of the N-terminal domain of focal adhesion kinase with the N-terminal transactivation domain of p53.
    Golubovskaya VM; Finch R; Cance WG
    J Biol Chem; 2005 Jul; 280(26):25008-21. PubMed ID: 15855171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FAK inhibition decreases cell invasion, migration and metastasis in MYCN amplified neuroblastoma.
    Megison ML; Stewart JE; Nabers HC; Gillory LA; Beierle EA
    Clin Exp Metastasis; 2013 Jun; 30(5):555-68. PubMed ID: 23208732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FAK deletion promotes p53-mediated induction of p21, DNA-damage responses and radio-resistance in advanced squamous cancer cells.
    Graham K; Moran-Jones K; Sansom OJ; Brunton VG; Frame MC
    PLoS One; 2011; 6(12):e27806. PubMed ID: 22194793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted Modulation of FAK/PI3K/PDK1/AKT and FAK/p53 Pathways by Cucurbitacin B for the Antiproliferation Effect Against Human Cholangiocarcinoma Cells.
    Klungsaeng S; Kukongviriyapan V; Prawan A; Kongpetch S; Senggunprai L
    Am J Chin Med; 2020; 48(6):1475-1489. PubMed ID: 32907364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FAK and Nanog cross talk with p53 in cancer stem cells.
    Golubovskaya VM
    Anticancer Agents Med Chem; 2013 May; 13(4):576-80. PubMed ID: 22934707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Focal adhesion kinase and p53 signaling in cancer cells.
    Golubovskaya VM; Cance WG
    Int Rev Cytol; 2007; 263():103-53. PubMed ID: 17725966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct FAK-Src activation events promote alpha5beta1 and alpha4beta1 integrin-stimulated neuroblastoma cell motility.
    Wu L; Bernard-Trifilo JA; Lim Y; Lim ST; Mitra SK; Uryu S; Chen M; Pallen CJ; Cheung NK; Mikolon D; Mielgo A; Stupack DG; Schlaepfer DD
    Oncogene; 2008 Feb; 27(10):1439-48. PubMed ID: 17828307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cloning and characterization of the promoter region of human focal adhesion kinase gene: nuclear factor kappa B and p53 binding sites.
    Golubovskaya V; Kaur A; Cance W
    Biochim Biophys Acta; 2004 May; 1678(2-3):111-25. PubMed ID: 15157737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heparin plays a key regulatory role via a p53/FAK-dependent signaling in melanoma cell adhesion and migration.
    Chalkiadaki G; Nikitovic D; Berdiaki A; Katonis P; Karamanos NK; Tzanakakis GN
    IUBMB Life; 2011 Feb; 63(2):109-19. PubMed ID: 21360640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p53-Dependent repression of focal adhesion kinase in response to estradiol in breast cancer cell-lines.
    Anaganti S; Fernández-Cuesta L; Langerød A; Hainaut P; Olivier M
    Cancer Lett; 2011 Jan; 300(2):215-24. PubMed ID: 21071137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unraveling the relationship between n-myc and Focal Adhesion Kinase (FAK) in neuroblastoma?
    Madonna MB
    Cell Cycle; 2010 May; 9(9):1679-80. PubMed ID: 20448460
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.